Search

Displaying results 3351 - 3360 of 10000 in total
  1. Drug

    Olipudase alfa

    go.drugbank.com/drugs/DB12835
    ApprovedInvestigational

    [A251590] Olipudase alfa gained its first global approval in Japan on March 28, 2022. … [L42740] ASMD is a rare lysosomal storage disease caused by mutations in the SMPD1 gene, leading to a deficiency in acid sphingomyelinase and the abnormal accumulation of the primary ASM substrate, sphingomyelin

  2. Drug

    Limaprost

    go.drugbank.com/drugs/DB09211
    Investigational

    numbness in the lower leg and walking disability associated with acquired lumbar spinal canal stenosis as an additional indication in 2001. … Ono and DSP also discontinued the development of limaprost alfadex for the additional indication of cervical spondylosis in 2008 due to the failure to demonstrate the anticipated efficacy in a Phase II

    Categories: Prostaglandins EProducts: OPALMON TABLETS 5 ug
  3. Drug

    AG-24322

    go.drugbank.com/drugs/DB13035
    Investigational

    AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.

  4. Drug

    MGD-024

    go.drugbank.com/drugs/DB17265
    Investigational

    MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.

  5. Drug

    Boron

    go.drugbank.com/drugs/DB11203
    ApprovedInvestigational

    Boron (B) is a chemical element with an atomic number 5 that belongs in the Period 2 and Group 13 in the periodic table. … additive in glass fibers of boron-containing fiberglass for insulation and structural materials.

    Mixtures: Ribotin-E, BIOGROW MIN
  6. Drug

    Mesocricetus auratus skin

    go.drugbank.com/drugs/DB10605
    Approved

    Mesocricetus auratus skin or pelt is used in allergenic testing.

    Synonyms: hamster skin extract, Mesocricetus auratus skinCategories: Non-Standardized Animal Skin Allergenic Extract
  7. Drug

    ISIS 14803

    go.drugbank.com/drugs/DB05803
    Investigational

    protein expression in cell culture. … ISIS 14803 is a 20-unit antisense phosphorothioate oligodeoxynucleotide that binds to hepatitis C virus (HCV) RNA at the translation initiation region of the internal ribosome entry site (IRES) and inhibits

  8. Drug

    TRK-250

    go.drugbank.com/drugs/DB18500
    Investigational

    TRK-250 is a small interfering RNA agent that targets human transforming growth factor-beta 1 (TGF-β1) messenger RNA.

  9. Drug

    Manganese citrate

    go.drugbank.com/drugs/DB14495
    Approved

    Mixtures: Collag-EN
  10. Drug

    Adrulipase alfa

    go.drugbank.com/drugs/DB15004
    Investigational

    MS-1819 is under investigation in clinical trial NCT03481803 (A Phase IIa Study With Escalating Dose of MS1819-SD).